EFFECTS OF PINACIDIL ON ARTERIAL AND VENOUS RESISTANCES AND MEAN CIRCULATORY FILLING PRESSURE IN RATS

被引:7
作者
WAITE, RP [1 ]
LIM, SL [1 ]
PANG, CCY [1 ]
机构
[1] UNIV BRITISH COLUMBIA,FAC MED,DEPT PHARMACOL & THERAPEUT,VANCOUVER,BC V6T 1Z3,CANADA
关键词
PINACIDIL; K CHANNEL OPENERS; MEAN CIRCULATORY FILLING PRESSURE (MCFP); CARDIAC OUTPUT; TOTAL PERIPHERAL RESISTANCE; VENOUS RESISTANCE; VENOUS COMPLIANCE; CAPACITANCE VESSELS;
D O I
10.1111/j.1476-5381.1995.tb15072.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of the potassium channel opener, pinacidil, on mean arterial pressure (MAP), mean circulatory filling pressure (MCFP), total peripheral resistance (TPR), cardiac output (GO) and resistance to venous return (RV) were studied in rats. 2 In pentobarbitone-anaesthetized rats given mecamylamine (ganglionic blocker, 3.7 mu g kg(-1)) and noradrenaline (1.5 mu g kg(-1) min(-1)) to suppress autonomic reflexes, pinacidil (60 and 180 mu g kg(-1) min(-1)), relative to the vehicle, reduced MAP and TPR in a dose-dependent manner but did not significantly alter CO, MCFP or R(nu). 3 Pinacidil (10-300 mu g kg(-1) min(-1)) caused similar increases in MCFP, an inverse index of venous compliance, and similar dose-dependent reductions in mean arterial pressure (MAP) in conscious, intact rats and rats infused with the ganglionic blocker, hexamethonium (150 mu g kg(-1) min(-1)). In rats with vasomotor tone elevated by the infusion of noradrenaline (1.5 mu g kg(-1) min(-1)), pinacidil caused markedly greater depressor responses but did not significantly alter MCFP. 4 Our results show that pinacidil is an efficacious vasodilator of arterial resistance blood vessels but has little venodilator activity.
引用
收藏
页码:2322 / 2326
页数:5
相关论文
共 28 条
[11]   ION CHANNEL EFFECTS OF PINACIDIL IN VASCULAR MUSCLE [J].
HERMSMEYER, K .
DRUGS, 1988, 36 :29-32
[12]   CROMAKALIM, A POTASSIUM CHANNEL ACTIVATOR - A COMPARISON OF ITS CARDIOVASCULAR HEMODYNAMIC PROFILE AND TISSUE-SPECIFICITY WITH THOSE OF PINACIDIL AND NICORANDIL [J].
LONGMAN, SD ;
CLAPHAM, JC ;
WILSON, C ;
HAMILTON, TC .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 (05) :535-542
[13]   EFFECT OF VASOPRESSIN ANTAGONIST AND SARALASIN ON REGIONAL BLOOD-FLOW FOLLOWING HEMORRHAGE [J].
PANG, CCY .
AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 245 (05) :H749-H755
[14]   THE EFFECTS OF NORADRENALINE, B-HT 920, METHOXAMINE, ANGIOTENSIN-II AND VASOPRESSIN ON MEAN CIRCULATORY FILLING PRESSURE IN CONSCIOUS RATS [J].
PANG, CCY ;
TABRIZCHI, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (02) :389-394
[15]  
PANG CCY, 1994, EFFECTS DRUGS VENOUS, P1
[16]   POTASSIUM CHANNEL OPENERS - PHARMACOLOGICAL AND CLINICAL ASPECTS [J].
QUAST, U .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1992, 6 (07) :279-293
[17]   DO THE K+ CHANNEL OPENERS RELAX SMOOTH-MUSCLE BY OPENING K+ CHANNELS [J].
QUAST, U .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (09) :332-337
[18]   MEAN CIRCULATORY FILLING PRESSURE - ITS MEANING AND MEASUREMENT [J].
ROTHE, CF .
JOURNAL OF APPLIED PHYSIOLOGY, 1993, 74 (02) :499-509
[19]  
SOUTHERTON JS, 1988, N-S ARCH PHARMACOL, V338, P310
[20]  
STEINBERG MI, 1988, J CARDIOVASC PHAR S2, V13, pS30